| abstract |
The invention relates to cyclopentathiophene carboxamides of formula (I.0) n n n n n n n n n n wherein R 1 , R 2 , R 3 , R 4 , and n are as defined herein, and pharmaceutically acceptable salts thereof. The invention also relates to the use of the cyclopentathiophene carboxamides of formula (I.0) for the treatment of diseases which can be influenced by antagonizing the activity mediated by the platelet activating factor receptor. |